Eu assessment of the efficacy of Bacillus Velez NRRL B-67259 as a feed additive for all growing poultry species
After assessment, the Panel was unable to reach a conclusion on the efficacy of Bacillus Velez NRRL B-67259 as a feed additive for all growing poultry species. Some of the original reports are as follows:
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the efficacy of a product consisting of spores of Bacillus velezensis NRRL B-67257 as a zootechnical additive for chickens for fattening, chickens reared for laying, turkeys for fattening, turkeys reared for breeding and minor poultry species. The additive has the tradename Correlink™ ABS1781 Bacillus. Turkeys reared for breeding and minor poultry species. The additive has the Tradename Correlink™ ABS1781 bacillus subtilis and is not currently authorised in the EU. It is intended for use in complete feed for the target species at a minimum inclusion level of 1.5 × 108 CFU/kg complete feed. In a previous opinion, minimum inclusion level of 1.5 × 108 Cfu /kg complete feed. In a previous opinion, the FEEDAP Panel could not conclude on the efficacy of the additive for the poultry species due to the potential cross-contamination of the control diets in two of the three studies provided. The applicant has provided supplementary information to exclude this possibility. The new data showed that the gene used as marker in the previous analyses is non-specific of the NRRL B-67259 strain, which precluded the adequate quantification of the active agent in the feeds used in the studies. Moreover, in a second analysis, the active agent could not be isolated from the field excreta samples collected from either the treated or the control group in the two formerly submitted efficacy studies. The Panel concluded that the methodology was not able to discriminate between the strain under assessment and the background. Additionally, two new efficacy trials with chickens for fattening were provided to support the efficacy of the additive. However, none could be further considered since the husbandry conditions in which the birds were kept were non-compliant with Directive 2007/43/EC. Therefore, the FEEDAP Panel was not in the position to conclude on the efficacy of Correlink™ ABS1781 for all growing poultry. The feedap panel was not in the position to conclude on the efficacy of Correlink™ abs1781 for all growing poultry species.
Looking for chemical products? Let suppliers reach out to you!
2026-06-04
-
Life Science Ingredients Industry Overview
This issue offers a deep exploration of the evolving pharmaceutical and nutrition landscape, combining data, analysis, and insight to reveal key industry shifts and emerging directions. Support online permanent download.Published in: Nov. 2025
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
VIV Health & Nutrition Asia 2026 Brings Together Innovation and Business Across the Animal Feed and Health Industry
-
European Commission Greenlights Innovative Feed Additives for Livestock Nutrition
-
EU Declares Safety of Nematophilic Fungus NCIMB 30336 Feed Additive for Herbivores
-
EU Greenlights Corynebacterium glutamicum KCCM 80185-Derived L-Isoleucine as Universal Animal Feed Supplement
-
Study found that Lactobacillus rhamnosus GCC-3 culture can improve intestinal and liver health and antiviral immunity of zebrafish
-
EU evaluates the safety and effectiveness of sweet fennel oil as a feed additive for dogs and cats and bitter fennel oil as a feed additive for all animals
-
The EU assesses the safety and efficacy of feed additives consisting of sodium and potassium ferrocyanide for all animals
-
The EU approved L-arginine produced by Corynebacterium glutamicum CGMCC 20516 as a feed additive for all animals
-
Evaluation of Application for renewal of Authorisation of urea as a feed additive for ruminants in the EU
-
Eu evaluates the safety and efficacy of dill oil as a feed additive for dogs and cats
Recommend Reading
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
-
Obesity Drugs Become Pharma’s Most Powerful Growth Engine
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
-
Zydus Lifesciences Blocked by Delhi High Court in Cancer Biosimilar Case $9.3 Billion Opdyta Patent Dispute Intensifies
-
Increased Cost-Side Support Drives Up Prices of Polyester Staple Fiber
-
Fundamentals Improve Temporarily, PTA Prices Rise Slightly
-
Sumitomo Chemical Unveils Breakthrough Pilot Plant for Direct Propylene from Ethanol Green Hydrogen as Byproduct
-
Kuraray H1 Net Profit Plunges 54 Percent Sales Fall to 399.96 Billion Yen Price Hikes Announced for GENESTAR
-
Wanhua Chemical Boosts TDI Capacity to 1.44 Million Tons New 360000-Ton Plant Launches Amid Global Maintenance Cycle